SEVERE NEUROTOXICITY FOLLOWING HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND THIOTEPA IN THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA: THE UK EXPERIENCE

被引：0
|
作者：
Hayden, J. [1 ]
Vivekanandan, S. [2 ]
Thorp, N. [3 ]
Mayles, H. [4 ]
Baker, A. [4 ]
Pizer, B. [1 ]
Horan, G. [5 ]
机构：
[1] Alder Hey Childrens NHS Fdn Trust, Paediat Oncol, Liverpool, Merseyside, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Paediat Oncol, Cambridge, England
[3] Clatterbridge Canc Ctr NHS Fdn Trust, Oncol, Wirral, Merseyside, England
[4] Clatterbridge Canc Ctr NHS Fdn Trust, Clin Radiotherapy, Wirral, Merseyside, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Clin Oncol, Cambridge, England
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-105
引用
收藏
页码：S172 / S173
页数：2
相关论文
共 50 条
  • [41] THE ROLE OF COMBAT (COMBINED ORAL METRONOMIC BIODIFFERENTIATING ANTIANGIOGENIC TREATMENT) IN HIGH-RISK AND RELAPSED MEDULLOBLASTOMA: A SINGLE INSTITUTION EXPERIENCE
    Chinnaswamy, Girish
    Sankaran, Hari
    Bhat, Vasudev
    Anand, K. C.
    Saroha, Megha
    Prasad, Maya
    Vora, Tushar
    Sahay, Ayushi
    Krishnatry, Rahul
    Pungavkar, Sona
    Janu, Amit
    Gupta, Tejpal
    Jalali, Rakesh
    Banavali, Shripad
    NEURO-ONCOLOGY, 2018, 20 : 48 - 48
  • [42] TREATMENT OF HIGH-RISK MEDULLOBLASTOMA AND PRIMITIVE NEUROECTODERMAL TUMORS WITH PREIRRADIATION CISPLATIN AND ETOPOSIDE
    KOVNAR, E
    KUN, L
    HOROWITZ, M
    ETCUBANAS, E
    DOUGLASS, E
    MULHERN, R
    SANFORD, R
    LANGSTON, J
    ANNALS OF NEUROLOGY, 1988, 24 (02) : 361 - 362
  • [43] HYPERFRACTIONATED LOW-DOSE (21 GY) RADIOTHERAPY FOR CRANIAL SKELETAL METASTASES IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Kushner, Brian H.
    Cheung, Nai-Kong V.
    Barker, Christopher A.
    Kramer, Kim
    Modak, Shakeel
    Yataghene, Karima
    Wolden, Suzanne L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 1181 - 1186
  • [44] High-risk Medulloblastoma-Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity
    Martin, Allison M.
    Jackson, Sadhana
    JAMA ONCOLOGY, 2021, 7 (09) : 1322 - 1323
  • [45] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres
    Sanganalmath, P.
    Lester, J. E.
    Bradshaw, A. G.
    Das, T.
    Esler, C.
    Roy, A. E. F.
    Toy, E.
    Lester, J. F.
    Button, M.
    Wilson, P.
    Comins, C.
    Atherton, P.
    Pickles, R.
    Foweraker, K.
    Walker, G. A.
    Keni, M.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 144 - 150
  • [46] Sequential chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from nine UK centres
    Bradshaw, A. G.
    Lester, J. E.
    Das, T.
    Esler, C.
    Branagan, J.
    Roy, A. E. F.
    Toy, E. W.
    Alip, A.
    Lester, J. F.
    Williams, R.
    Kinsman, J.
    Comins, C.
    Atherton, P.
    Knox, C.
    Morgan, S.
    Walker, G. A.
    Hatton, M. Q.
    LUNG CANCER, 2014, 83 : S54 - S54
  • [47] The Role of Modified COMBAT (Combined Oral Metronomic Biodifferentiating Antiangiogenic Treatment) in High-Risk and Relapsed Medulloblastoma: A Single Institution Experience
    Bhat, V.
    Chinnaswamy, G.
    Vora, T.
    Prasad, M.
    Sankaran, H.
    Anand, K. C.
    Epari, S.
    Jain, A.
    Gupta, T.
    Krishnatry, R.
    Janu, A.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S427 - S428
  • [48] Preradiotherapy chemotherapy and hyperfractionated craniospinal radiotherapy for high-risk primitive neuroectodermal tumors: A preliminary report of CCG protocol 9931
    Allen, J
    Prados, M
    Donahue, B
    Mehta, M
    Robertson, P
    Jakacki, R
    Sposto, R
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 526 - 527
  • [49] DESENSITIZATION TO INTRAVENOUS IRON FOLLOWING SEVERE ANAPHYLAXIS IN A HIGH-RISK PATIENT
    Jung, H.
    Weinberger, T.
    McGoey, B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S57 - S58
  • [50] Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors - Review of the literature
    Jakacki, RI
    JOURNAL OF NEUROSURGERY, 2005, 102 (01) : 44 - 52
12345